Skip to main content
Science & Medicine· Daily Pulse

The First Months Off Meth Feel Stuck Because Your Brain Is Stuck. A New Study Shows It Loosens.

Brain scans of 40 people quitting methamphetamine found rigid, repetitive patterns early on, tied to stronger cravings. By eight months, the patterns had started to ease.

ByThe Rize NewsroomNovember 17, 20262 min readMethamphetamine

Ask anyone who has stopped using meth about the first few months and you’ll hear the same few words: flat, foggy, stuck. Nothing feels good. The same thoughts loop. The craving shows up out of nowhere. A study published this week in Translational Psychiatry suggests the “stuck” is literal, and it doesn’t last.

The worst months of quitting meth are a brain stuck in a rut. Ruts wear down, but only if you stay alive and supported long enough for it to happen.

A team led by first author Q. Song scanned 40 people with severe methamphetamine use disorder and 41 people without it. They scanned the patients twice: early in abstinence (three and a half months or less) and again after at least eight months. They weren’t looking at single brain regions. They were watching how the whole brain moves between its main patterns of activity. Early on, the brains of people quitting meth tended to lock into a few dominant patterns and stay there longer. They spent less time in the in-between states where the brain is more flexible. The more rigid the pattern, the stronger the craving people reported. By eight months, that rigidity had partly eased.

In plain terms: if the early months feel like your mind keeps landing in the same groove, that matches what the scans showed. It also matches what the scans showed later. The groove gets shallower. The researchers could even use the early scans to modestly predict whose cravings would shift over time.

Keep the limits in view. This is 40 people, scanned twice, in one research setting, with moderate correlations and no randomized treatment. It doesn’t prove that the brain changes cause the cravings. It doesn’t tell anyone how to speed up the recovery. It is one more piece of evidence for something people in recovery have long said and researchers keep confirming: early abstinence from stimulants is a distinct, hard phase with a biological signature, and it eases.

That has a practical consequence. There is still no FDA-approved medication for meth use disorder, and treatment options remain thin. In Missouri, 29% of people entering state-funded treatment named meth as their main drug. The best-supported tool is contingency management, small, reliable rewards for negative drug tests. A 2021 meta-analysis in JAMA Psychiatry found it had a medium-to-large effect on stimulant use, though that analysis covered people already on opioid-treatment medication. This week, if you run a program, look at what you offer in months one through four. That’s when patients feel worst and drop out most. Front-load the support there: more frequent check-ins, reward-based incentives if you can bill for them, and sleep and mood care.

If you’re in those months now, the flatness isn’t who you are. It’s where your brain is right now, and the scans say it moves.

Filed Under

psychologybiologyscienceMethamphetaminePeer-Reviewed ResearchRelapse PreventionContingency ManagementThe Treatment Gap

Keep up with the reporting.

One email each morning with the stories that put days like this in context.

A daily, no-spam briefing. Unsubscribe anytime.

Continue reading

More from this section